home / stock / nvcr / nvcr quote
Last: | $18.04 |
---|---|
Change Percent: | 0.48% |
Open: | $18.63 |
Close: | $18.04 |
High: | $18.63 |
Low: | $18 |
Volume: | 1,215,293 |
Last Trade Date Time: | 06/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$18.04 | $18.63 | $18.04 | $18.63 | $18 | 1,215,293 | 06-25-2024 |
$18.72 | $19.07 | $18.72 | $19.23 | $18.595 | 849,418 | 06-24-2024 |
$19.07 | $19.31 | $19.07 | $19.545 | $18.9 | 1,299,498 | 06-21-2024 |
$19.175 | $19.2 | $19.175 | $19.85 | $19.12 | 865,667 | 06-20-2024 |
$19.44 | $19.27 | $19.44 | $19.99 | $19.175 | 876,270 | 06-19-2024 |
$19.44 | $19.27 | $19.44 | $19.99 | $19.175 | 876,270 | 06-18-2024 |
$19.4 | $21.24 | $19.4 | $21.34 | $18.92 | 1,971,735 | 06-17-2024 |
$21.34 | $21.28 | $21.34 | $21.42 | $20.9705 | 885,646 | 06-14-2024 |
$21.52 | $21.28 | $21.52 | $21.865 | $21.02 | 1,098,841 | 06-13-2024 |
$21.25 | $22.25 | $21.25 | $22.44 | $20.97 | 945,440 | 06-12-2024 |
$21.41 | $21.2 | $21.41 | $21.61 | $20.9 | 948,895 | 06-11-2024 |
$21.46 | $21.28 | $21.46 | $21.915 | $21.2601 | 699,525 | 06-10-2024 |
$21.5 | $21.56 | $21.5 | $21.8022 | $21.2 | 1,193,416 | 06-07-2024 |
$22.15 | $22.82 | $22.15 | $22.991 | $21.96 | 1,045,657 | 06-06-2024 |
$23.13 | $22.97 | $23.13 | $23.51 | $22.6101 | 762,100 | 06-05-2024 |
$22.82 | $24.29 | $22.82 | $24.4 | $22.49 | 1,150,047 | 06-04-2024 |
$23.89 | $22.77 | $23.89 | $24.04 | $22.42 | 1,507,683 | 06-03-2024 |
$22.01 | $22.64 | $22.01 | $23.19 | $21.9 | 1,483,720 | 05-31-2024 |
$22.27 | $22.45 | $22.27 | $22.665 | $22.02 | 1,206,916 | 05-30-2024 |
$22.01 | $21.61 | $22.01 | $22.28 | $21.45 | 1,590,411 | 05-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
NovoCure Limited Company Name:
NVCR Stock Symbol:
NASDAQ Market:
2024-06-13 14:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-04 10:45:03 ET Wells Fargo analyst issues NEUTRAL recommendation for NVCR on June 4, 2024 09:01AM ET. The previous analyst recommendation was Neutral. NVCR was trading at $24.055 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cur...
The METIS trial demonstrated 21.9 months median time to intracranial progression for patients treated with TTFields therapy and supportive care compared to 11.3 months for patients treated with supportive care alone Patients treated with TTFields therapy experienced prolonged quality of l...